Skip to content
Sign in
Venture capitalBacked 1 network startup

IAG Capital Partners

US investor with no profile in our data; participated in Neurosoft Bioelectronics' oversubscribed $7.5M seed.

United States
Ticket
—Not published
Assets under management
—
Founded
—
Stages
—
Network startups backed
1
Co-investors
3most often with Connecticut Innovations

How they invest

Unknown — no thesis. One observed deal in brain-computer interfaces.

Stage and ticket

Observed at seed ($7.5M round, 2026).

Geography

United States (HQ).

What makes them say yes

  • Neurotech / medtech (inferred)
  • Oversubscribed rounds with strong syndicate
  • Swiss/US deep tech

Red flags

  • No published thesis, ticket or stage policy in our data — any approach is a cold qualification call
  • Pitching outside the single sector signal visible in its known deal

Sectors

Not published

Stages

Not published

Geographies

Not published

How to approach

Ask Neurosoft's founders or co-investors (Skybound, PL Capital) for context.

Portfolio

1 network startup · no other company

Single BCI deal alongside Connecticut Innovations, PL Capital and Skybound.

Gaps in the portfolio

  • Unknown thesis

Network startups

  • Neurosoft BioelectronicsSWC 2026 Finalist

    EPFL spin-off making soft, stretchable cortical electrodes for minimally invasive brain interfaces, with first-in-human epilepsy data and a $7.5M seed.

    Switzerland · MedTech & devices

    • Seed (oversubscribed) · $7.5M · 1 May 2026Source

Network startups that fit

3 analysed

IIT spin-off selling SiNAPS CMOS neural probes with 1,024 active electrodes for high-density brain recording, an option on brain-computer interfaces.

Italian neural probes at seed — direct neurotech analogue to Neurosoft.

35%confidence

Evidence from the records

  • “Neurosoft Bioelectronics”
  • “Neurotechnology / neural probes”
  • “The website has a products section and terms of sale, but no customer or user lab is published (conservative estimate).”
Intro path
Founder-to-founder intro via Neurosoft Bioelectronics (network portfolio company of IAG Capital Partners).
First step
Ask Neurosoft for an introduction.

Lisbon spin-off selling a contactless AI bedside lamp that detects night-time epileptic seizures and alerts caregivers.

Portuguese seizure-detection device — neurology medtech.

25%confidence

Evidence from the records

  • “Seed (oversubscribed)”
  • “Epileptic seizure detection”
  • “Lamp on sale in the EU ("Order Now"), validated by European hospitals according to the company”
Intro path
Founder-to-founder intro via Neurosoft Bioelectronics (network portfolio company of IAG Capital Partners).
First step
Low priority.

FDA-cleared low-cost automated peritoneal dialysis cycler, built in a DRAP-approved Pakistani factory, preparing first US patients.

US at-home peritoneal dialysis at seed — US medtech, different therapy area.

20%confidence

Evidence from the records

  • “Neurosoft”
  • “At-home peritoneal dialysis”
  • “X-1 APD cycler and DS-1 set: FDA 510(k) clearance K243371 (decision of 16 May 2025, class II)”
Intro path
Founder-to-founder intro via Neurosoft Bioelectronics (network portfolio company of IAG Capital Partners).
First step
Low priority.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai.

Co-investors

Most often with Connecticut Innovations, PL Capital (Protocol Labs), and Skybound Venture Capital

Sources

  1. 1tech.eu/2026/05/20/neurosoft-bioelectronics-raises-75m-for-scalable

Profile compiled from public sources. Unknown fields are left empty rather than estimated.